Physician profile
Laura E Towne
NPI 1407943046
$279.19
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $79.67 · 2021: $23.89.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $77.32 | 2019-2021 | |
| Genzyme Corporation | $53.29 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $44.56 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $23.45 | 2019 | |
| Sebela Pharmaceuticals INC. | $14.98 | 2019 | |
| Biofrontera INC. | $13.82 | 2019 | |
| Genentech USA, INC. | $13.56 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.53 | 2020 | |
| Galderma Laboratories, L.P. | $13.42 | 2019 | |
| Leo Pharma INC. | $11.26 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Towne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.